Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma

Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma

Interactive session on hepatocellular cancer guidelines - New agents on the horizon in HCCПодробнее

Interactive session on hepatocellular cancer guidelines - New agents on the horizon in HCC

Advanced HCC - Management Strategies for Emerging Targeted TherapiesПодробнее

Advanced HCC - Management Strategies for Emerging Targeted Therapies

Exploring Current and Upcoming Therapies for Hepatocellular CarcinomaПодробнее

Exploring Current and Upcoming Therapies for Hepatocellular Carcinoma

NEVER IGNORE These 10 Signs of CancerПодробнее

NEVER IGNORE These 10 Signs of Cancer

Hepatocellular Carcinoma: A Guide to Integrating Emerging Therapies into Current Treatment ParadigmsПодробнее

Hepatocellular Carcinoma: A Guide to Integrating Emerging Therapies into Current Treatment Paradigms

Evaluating Systemic Therapies Available for Frontline Treatment of HCCПодробнее

Evaluating Systemic Therapies Available for Frontline Treatment of HCC

Evaluating Current Challenges in Hepatocellular CarcinomaПодробнее

Evaluating Current Challenges in Hepatocellular Carcinoma

Stephen Lyle - Personalized medicineПодробнее

Stephen Lyle - Personalized medicine

Molecular Targeted Therapies for Advanced HCCПодробнее

Molecular Targeted Therapies for Advanced HCC

GRACE Targeted Therapies Lung Cancer 2021 - KRAS Directed Therapies: A New HorizonПодробнее

GRACE Targeted Therapies Lung Cancer 2021 - KRAS Directed Therapies: A New Horizon

Novel treatments for HCC in the era of Hep C therapiesПодробнее

Novel treatments for HCC in the era of Hep C therapies

Current and future targeted therapies in cholangiocarcinomaПодробнее

Current and future targeted therapies in cholangiocarcinoma

Adjuvant and neoadjuvant approaches in early-stage HCCПодробнее

Adjuvant and neoadjuvant approaches in early-stage HCC

HCC: Emerging TherapiesПодробнее

HCC: Emerging Therapies

"Hepatocellular Carcinoma: Molecular Diagnostics, Prognosis...."Подробнее

'Hepatocellular Carcinoma: Molecular Diagnostics, Prognosis....'

A new molecular target for overcoming liver cancer’s resistance to therapyПодробнее

A new molecular target for overcoming liver cancer’s resistance to therapy

The emerging role of checkpoint inhibitors in liver cancerПодробнее

The emerging role of checkpoint inhibitors in liver cancer

Emerging Therapies in Advanced HCCПодробнее

Emerging Therapies in Advanced HCC

New Molecularly Guided Therapies in Advanced/Metastatic Cholangiocarcinoma: What You Need to KnowПодробнее

New Molecularly Guided Therapies in Advanced/Metastatic Cholangiocarcinoma: What You Need to Know